Wellgistics Health Reports Stability and Growth Initiatives in Mid-2025

Wellgistics Health, Inc. (NASDAQ: WGRX) announced its financial results for the second quarter of 2025. Revenue reached $18.65 million in the first half of 2025, a slight increase from $18.25 million in the same period in 2024. Mark DiSiena, CFO, highlighted disciplined execution and a stronger balance sheet as key developments. The company is undergoing a transformation towards a more technology-driven and innovative organization.

Since its IPO in February 2025, Wellgistics Health has focused on three main initiatives: operational integration, governance improvements, and technological advancements. Significant steps include merging Wellgistics LLC and Wood Sage LLC, streamlining staffing, and upgrading their ERP system. The company also converted $10.1 million of debt into common stock equity, enhancing financial flexibility.

Wellgistics Health is actively scaling its direct-to-patient programs, aiming to expand in areas such as diabetes, weight loss, and chronic pain. CEO Brian Norton emphasizes the company’s commitment to improving patient access through its national network of pharmacies and manufacturers.